HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David E Kaplan Selected Research

End Stage Liver Disease

1/2022Modeling Optimal Clinical Thresholds for Elective Abdominal Hernia Repair in Patients With Cirrhosis.
1/2022Risk Prediction Models for Postoperative Decompensation and Infection in Patients With Cirrhosis: A Veterans Affairs Cohort Study.
1/2021Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.
1/2021External Validation of the VOCAL-Penn Cirrhosis Surgical Risk Score in 2 Large, Independent Health Systems.
1/2021Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries.
1/2021The Predictive Role of Model for End-Stage Liver Disease-Lactate and Lactate Clearance for In-Hospital Mortality Among a National Cirrhosis Cohort.
7/2020Models for acute on chronic liver failure development and mortality in a veterans affairs cohort.
1/2020Risk prediction scores for acute on chronic liver failure development and mortality.
11/2017Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David E Kaplan Research Topics

Disease

42Fibrosis (Cirrhosis)
12/2023 - 06/2008
33Hepatocellular Carcinoma (Hepatoma)
01/2023 - 08/2003
17Infections
01/2023 - 06/2005
15Neoplasms (Cancer)
01/2023 - 08/2003
14Liver Diseases (Liver Disease)
01/2023 - 10/2017
9End Stage Liver Disease
01/2022 - 11/2017
7COVID-19
01/2023 - 01/2022
6Hepatitis C
10/2020 - 08/2003
5Hemorrhage
01/2022 - 12/2019
4Non-alcoholic Fatty Liver Disease
01/2022 - 01/2020
4Liver Neoplasms (Liver Cancer)
01/2021 - 11/2017
3Viremia
01/2023 - 06/2008
3Chronic Hepatitis C
10/2022 - 06/2005
3Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2020
3Ascites
10/2021 - 12/2015
3Portal Hypertension
01/2021 - 01/2021
3Hepatitis B
01/2019 - 08/2003
2Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 06/2020
2Fatty Liver
01/2024 - 01/2021
2Acute-On-Chronic Liver Failure
06/2023 - 01/2022
2Ischemic Stroke
10/2021 - 01/2021
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
08/2021 - 01/2021
2Virus Diseases (Viral Diseases)
11/2017 - 06/2008
2Persistent Infection
12/2015 - 06/2008
2Chronic Hepatitis (Chronic Active Hepatitis)
06/2008 - 08/2003
1Pancreatic Cyst
01/2024
1Gallstones (Gallstone)
01/2024
1Adenocarcinoma
10/2023
1Alcoholism (Alcohol Abuse)
01/2023
1Alcoholic Hepatitis
01/2022
1Genetic Risk Score
10/2021
1Cardiovascular Diseases (Cardiovascular Disease)
10/2021
1Coronary Disease (Coronary Heart Disease)
10/2021
1Diabetes Mellitus
10/2021
1Thrombosis (Thrombus)
01/2021

Drug/Important Bio-Agent (IBA)

9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2023 - 08/2018
8Sorafenib (BAY 43-9006)FDA Link
01/2023 - 11/2017
8Antiviral Agents (Antivirals)IBA
10/2022 - 06/2005
8SodiumIBA
01/2022 - 11/2017
7VaccinesIBA
01/2023 - 08/2003
7Cytidine Triphosphate (CTP)IBA
01/2023 - 12/2015
5Alanine Transaminase (SGPT)IBA
04/2024 - 04/2015
4Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2012
4AntigensIBA
01/2021 - 06/2005
3BilirubinIBA
01/2024 - 01/2021
3mRNA VaccinesIBA
01/2023 - 10/2022
3Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2023 - 01/2021
3Messenger RNA (mRNA)IBA
11/2022 - 06/2020
3Peptides (Polypeptides)IBA
06/2020 - 06/2008
3InterferonsIBA
01/2016 - 09/2011
3GlypicansIBA
05/2015 - 06/2011
2AlbuminsIBA
01/2024 - 01/2021
2NivolumabIBA
01/2023 - 10/2019
2BNT162 VaccineIBA
11/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 04/2015
2Metformin (Glucophage)FDA LinkGeneric
10/2021 - 10/2021
2EnzymesIBA
10/2021 - 06/2008
2DNA (Deoxyribonucleic Acid)IBA
10/2020 - 01/2016
2Hepatitis B e AntigensIBA
10/2020 - 01/2016
2Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2017 - 01/2016
2Ribavirin (Virazole)FDA LinkGeneric
01/2017 - 09/2011
2Interferon-gamma (Interferon, gamma)IBA
06/2011 - 02/2007
2CytokinesIBA
07/2009 - 06/2008
1TransferasesIBA
04/2024
1Alkaline PhosphataseIBA
01/2024
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2024
1Triglycerides (Triacylglycerol)IBA
01/2024
1Proteins (Proteins, Gene)FDA Link
01/2024
1Blood Glucose (Blood Sugar)IBA
12/2023
1Anti-Bacterial Agents (Antibiotics)IBA
10/2023
1Carvedilol (Coreg)FDA LinkGeneric
01/2023
1Naltrexone (ReVia)FDA LinkGeneric
01/2023
1COVID-19 VaccinesIBA
01/2023
1Acamprosate (Campral)FDA Link
01/2023
12019-nCoV Vaccine mRNA-1273IBA
11/2022
1NucleotidesIBA
01/2022
1Ranitidine (Zantac)FDA LinkGeneric
01/2022
1Proton Pumps (Proton Pump)IBA
01/2022
1O(4)-methylthymidine triphosphateIBA
01/2022
1Proton Pump InhibitorsIBA
01/2022
1AcidsIBA
01/2022
1Apoptosis Regulatory ProteinsIBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
10/2021
1AngiotensinogenIBA
10/2021
1AngiotensinsIBA
10/2021
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
10/2021
1Sodium-Glucose Transport ProteinsIBA
10/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
10/2021
1obeticholic acidIBA
08/2021

Therapy/Procedure

21Therapeutics
06/2023 - 08/2003
8Liver Transplantation
01/2023 - 01/2018
6Transplantation
08/2021 - 08/2003
4Aftercare (After-Treatment)
01/2021 - 11/2017
3Operative Surgical Procedures
01/2021 - 01/2019
1Glycemic Control
12/2023
1Gastrectomy
01/2023
1Ambulatory Care (Outpatient Care)
11/2022
1Transjugular Intrahepatic Portasystemic Shunt
01/2022
1Precision Medicine
11/2021
1Drug Therapy (Chemotherapy)
10/2021